Marksans Pharma Ltd

MARKSANS

Company Profile

  • Business description

    Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal, and oncologic drugs as well as antibiotics and antiallergic medications. Geographically, the majority of its revenue is generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, and the Rest of the World.

  • Contact

    Veera Desai Extension Road
    11th Floor, Grandeur
    Opposite Gundecha Symphony
    Oshiwara, Andheri (West)
    MumbaiMH400053
    IND

    T: +91 2240012000

    https://www.marksanspharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2026

    Employees

    2,657

Stocks News & Analysis

stocks

What AI means for US software companies’ moats

We’re no longer certain that software firms will outperform over the next decade, but positive outcomes remain possible for names like Salesforce.
stocks

Lower moat ratings on four ASX shares due to AI

We believe AI weakens the competitive advantage of these companies.
stocks

What Q4 US earnings did and didn’t tell us about AI and the outlook for tech shares

Tech saw solid earnings, but there are more questions around which companies will benefit from AI, and which will be hurt.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,823.6016.90-0.19%
CAC 407,818.53174.96-2.19%
DAX 4023,153.99437.04-1.85%
Dow JONES (US)46,642.72858.83-1.81%
FTSE 10010,147.21137.54-1.34%
HKSE25,408.46348.83-1.35%
NASDAQ22,090.37297.31-1.33%
Nikkei 22552,728.722,892.12-5.20%
NZX 50 Index13,098.83519.06-3.81%
S&P 5006,639.14100.88-1.50%
S&P/ASX 2008,599.003.30-0.04%
SSE Composite Index4,096.6027.59-0.67%

Market Movers